DKSH, the leading Market Expansion Services provider with a focus on Asia provides in Hong Kong distribution, logistics and collection services to Nong's Company Limited, the leading manufacturer of concentrated Chinese Medicine granules
HONG KONG, Nov. 8, 2012 /PRNewswire/ -- DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, signed an agreement with Nong's to provide sales logistics, distribution, as well as credit and collection services for Nong's medical products in Hong Kong.
"We started working with DKSH ten years ago and have now extended our collaboration for another five years. Based on our past experience, we are confident that this long-term collaboration will bring both companies further successes in the years to come. Being a reliable partner and a high-quality service benchmark leader, DKSH is supporting our business operations in a very positive, proactive and efficient way. DKSH is always on our side to assist and stand by us and has helped us grow our business turnover more than 100 times since the beginning of our collaboration," said Calvin Chan, Managing Director, Nong's Company Limited.
"We are proud to be extending and intensifying our partnership with Nong's and representing one of the strongest Traditional Chinese Medicine brands. Chinese medicine has always been popular in Hong Kong. With the increasing health consciousness of the rising middle class coupled with the trend towards increasing preference for natural organic products, we are seeing more end consumers turning to alternative medicine such as Chinese medicine. We are confident that we will be able to further support Nong's in growing their business in Hong Kong," commented Richard Holloway, Vice President, DKSH Healthcare Hong Kong. "At the same time, with a portfolio of leading Consumer Health brands, we will continue leveraging our comprehensive network and relationships to provide Hong Kong consumers access to ever more excellent brands."
About DKSH
DKSH is the leading Market Expansion Services Group with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich, with 650 business locations in 35 countries -- 630 of them in Asia, and 26,000 specialized staff. In 2011, DKSH generated net sales of CHF 7.3 billion.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, offering a wide range of solutions that extend from product feasibility studies and registration to importation, customs clearance, marketing and sales, to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices.
With 150 business locations in 13 countries and over 8,000 specialized staff, Business Unit Healthcare serves over 160,000 customers and generated net sales of around CHF 2.9 billion in 2011.
About Nong's
Nong's Company Limited is a wholly-owned subsidiary of PuraPharm Corporation Ltd. It is the largest manufacturer of concentrated Chinese Medicine granule in Hong Kong.
PuraPharm upholds both the wisdom of TCM and Research and Development, and have a corporate vision to modernize Chinese Medicine. Today, its Nong's brand carries a range of over 750 concentrated Chinese Medicine granules and has business in Hong Kong, Mainland China, Macau, Philippines, United States, United Kingdom, Singapore, Australia and Canada.
In 2004, PuraPharm Nanning Pharmaceuticals Co., Ltd. was named one of the only six approved manufacturers by the State Food and Drug Administration (SFDA) in China to produce and distribute Chinese medicine granules. It is the first and only Hong Kong-invested manufacturer to attain the permit. Its factory in Nanning has obtained GMP certificate from both State Food and Drug Administration (SFDA) of China and Therapeutic Goods Administration (TGA) of Australia, indicating it has reached the world-class manufacturing standard.
To know more about PuraPharm, please visit www.purapharm.com
To know more about Nong's, please visit www.nongs.com
For further information, please contact:
DKSH Hong Kong Limited
Amy Tam
Corporate Communications Manager
amy.tam@dksh.com
Phone +852-2895-9610
Fax +852-2895-9711
DKSH Healthcare
Michael Hofer
Communications Manager
Business Unit Healthcare
michael.hofer@dksh.com
Phone +66-2-730-3177
Nong's
Calvin Chan
Managing Director
Nong's Company Limited
info@purapharm.com
Phone +852-2840-1840
